A Comparative Study of Antibiotic Use in China under Chinese Restriction List and World Health Organization AWaRe Classification.

Haishaerjiang Wushouer,Yaoyao Yang,Yanping Deng,Bo Zheng,Luwen Shi,Xiaodong Guan

DOI: https://doi.org/10.1016/j.cmi.2022.12.011

2022-01-01

Abstract:Antimicrobial resistance (AMR) represents a major threat to human health with significant global economic and security implications. To improve the rational use of antibiotics, in 2017, the WHO introduced the Access, Watch, and Reserve (AWaRe) classification of antibiotics for the evaluation and monitoring of use and set up a global target to reduce AMR, i.e. by 2023, 60% of all antibiotics consumed must come from Access—the group of antibiotics at lowest risk of resistance [1]. China is one of the largest consumers of antibiotics in the world and is also under the threat of AMR [2].